Pediatric refractory epilepsy related to tuberous sclerosis complex: A retrospective-cohort study of diagnosis and

Rongbo Lin1, Zhao Liao2, Lingyu Kong3

  • 1Department of Neurology, Shenzhen Children's Hospital, Shenzhen, China 518038, China; Department of Emergency, Shenzhen Children's Hospital, Shenzhen, China 518038, China.

Seizure
|June 25, 2025
PubMed

Insights

Refractory epilepsy (RE) in tuberous sclerosis complex (TSC) is linked to infantile spasms, TSC2 mutations, and lesion type. Early intervention with vigabatrin and sirolimus may reduce RE occurrence in pediatric patients.

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • Tuberous sclerosis complex (TSC) frequently leads to refractory epilepsy (RE).
  • Identifying risk factors for RE in TSC is crucial for effective management.
  • This study investigates various factors contributing to RE in pediatric TSC patients.

Purpose of the Study:

  • To identify significant risk factors for refractory epilepsy (RE) in pediatric patients with tuberous sclerosis complex (TSC).
  • To analyze the correlation between clinical data, treatment, genetic factors, and RE development.
  • To provide insights for early intervention strategies to mitigate RE in TSC.

Main Methods:

  • A cohort of 315 pediatric TSC patients with epilepsy was divided into control and RE groups.
  • Multimodal data including clinical, genetic, imaging, and EEG findings were analyzed.
  • Risk factors for RE were characterized using statistical analysis.

Main Results:

  • Infantile spasms, TSC2 mutations, clustered seizures, family history, and specific lesion types (II and III) were positively correlated with RE.
  • Early age of onset and vigabatrin use showed a negative correlation with RE.
  • Lesion type, particularly type II, was a significant predictor of RE risk, increasing it by 1.63-fold.

Conclusions:

  • Key risk factors for RE in TSC include early age of onset, infantile spasms, type II lesions, TSC2 mutations, family history, and clustered seizures.
  • Anti-seizure medication (ASM) is recommended even with subclinical EEG findings.
  • Early use of vigabatrin and sirolimus may decrease the incidence of RE in children with TSC.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
296
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
612
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
205